Physician profile
Scott C Adrian
NPI 1669884946
$58,067.38
in general payments reported to CMS, 2019-2025
13 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $13K · 2021: $1,552 · 2022: $8,376 · 2023: $107 · 2024: $203 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $27,315.50 | 2019-2022 | |
| Smith+Nephew, INC. | $16,608.22 | 2019-2021 | |
| Titan Surgical Group, LLC | $6,599.62 | 2020-2025 | |
| Alon Medical Technology | $4,087.72 | 2019-2020 | |
| Stryker Corporation | $2,023.59 | 2019-2024 | Augment Injectable, 7 X 23mm Citrelock Implant, Ortholoc 2 Lapifuse |
| Zimmer Biomet Holdings, INC. | $644.49 | 2021-2024 | Tapestry |
| Medical Device Business Services, INC. | $298.99 | 2019 | |
| Depuy Synthes Sales INC. | $213.95 | 2019-2023 | |
| Lima USA, INC. | $124.14 | 2020 | |
| Ferring Pharmaceuticals INC. | $48.00 | 2025 | Euflexxa |
| Linvatec Corporation | $45.14 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $32.08 | 2025 | |
| Abbvie INC. | $25.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Adrian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.